YOUR SEARCH FOR Text 261 RESULTS
101 of Total
Q2 2025 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q2 2025 Incyte Corporation Earnings Conference Call Jul 29, 2025 at 8:00 AM EDT Click here
102 of Total
Q3 2022 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q3 2022 Incyte Corporation Earnings Conference Call Nov 1, 2022 at 8:00 AM EDT Click here for
103 of Total
Q3 2023 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q3 2023 Incyte Corporation Earnings Conference Call Oct 31, 2023 at 8:00 AM EDT Click here
104 of Total
Q3 2024 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q3 2024 Incyte Corporation Earnings Conference Call Oct 29, 2024 at 8:00 AM EDT Click here
105 of Total
Q3 2025 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q3 2025 Incyte Corporation Earnings Conference Call Oct 28, 2025 at 8:00 AM EDT Click here
106 of Total
Q4 2023 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q4 2023 Incyte Corporation Earnings Conference Call Feb 13, 2024 at 8:00 AM EST Click here
107 of Total
Q4 2024 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q4 2024 Incyte Corporation Earnings Conference Call Feb 10, 2025 at 8:00 AM EST Click here
108 of Total
Q4/YE 2022 Incyte Corporation Earnings Conference Call | Incyte
Events Corporate Presentations Scientific Presentations Q4/YE 2022 Incyte Corporation Earnings Conference Call Feb 7, 2023 at 8:00 AM EST Click here
109 of Total
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a
View all news Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse
110 of Total
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results | Incyte
View all news Incyte to Report Fourth Quarter and Year-End 2025 Financial Results January 27, 2026 at 8:00 AM EST PDF Version WILMINGTON, Del. --(